April 19, 2024
Stocks & Bonds
[STOCK WATCH] Ilyang Pharmaceutical rises 1.66%
[THE INVESTOR] As of Apr. 25 10:25 A.M., Ilyang Pharmaceutical increased 1.66%, compared with yesterday, to 39,800 won. It had increased 3.92% through the past month. Standard deviation, the risk index for stock price, was 2.1% on the same period of time over one month.
Compared with its close competitors within the same industry, KOSPI, the monthly earnings rate of Ilyang Pharmaceutical was proper, while its volatility within 1 month was relatively lower than that of its peer group's. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was 1.8. Though its volatility was low, the return-on-risk on the whole was at the median. And compared with the KOSPI industry, the return-on-risk of Ilyang Pharmaceutical is around the industrial mean, 1.8, and thus the industrial comparison performance was not bad.
By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.
Compared with its close competitors within the same industry, KOSPI, the monthly earnings rate of Ilyang Pharmaceutical was proper, while its volatility within 1 month was relatively lower than that of its peer group's. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was 1.8. Though its volatility was low, the return-on-risk on the whole was at the median. And compared with the KOSPI industry, the return-on-risk of Ilyang Pharmaceutical is around the industrial mean, 1.8, and thus the industrial comparison performance was not bad.
By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.
